JESSICA EDWARDS
- Type
- Physician · Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Psychiatry
- Where
- KING, NC
- NPI
- 1205011087
- Received
- $10,833 in 340 records, 2019 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 133 | $3,279 |
| 2024 | General payment | 72 | $2,559 |
| 2023 | General payment | 43 | $1,470 |
| 2022 | General payment | 29 | $660 |
| 2021 | General payment | 24 | $919 |
| 2020 | General payment | 22 | $710 |
| 2019 | General payment | 17 | $1,235 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | 54 | $2,784 | 2019–2025 |
| Alkermes, Inc. | 87 | $2,426 | 2019–2025 |
| ABBVIE INC. | 53 | $1,141 | 2021–2025 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 27 | $797 | 2021–2025 |
| Tris Pharma Inc | 20 | $541 | 2023–2025 |
| Allergan, Inc. | 7 | $466 | 2019–2020 |
| Vanda Pharmaceuticals Inc. | 10 | $417 | 2024–2025 |
| Neurocrine BioSciences, Inc. | 14 | $376 | 2023–2025 |
| Sunovion Pharmaceuticals Inc. | 8 | $363 | 2019–2020 |
| Otsuka America Pharmaceutical, Inc. | 14 | $261 | 2024–2025 |
| Axsome Therapeutics, Inc. | 7 | $248 | 2024–2025 |
| Teva Pharmaceuticals USA, Inc. | 8 | $245 | 2020–2025 |
| E.R. Squibb & Sons, L.L.C. | 5 | $236 | 2024–2025 |
| Collegium Pharmaceutical, Inc. | 11 | $153 | 2025 |
| Almatica Pharma LLC | 6 | $125 | 2024–2025 |
| Biogen, Inc. | 1 | $100 | 2024 |
| Neos Therapeutics, LP | 2 | $37 | 2024–2025 |
| Lundbeck LLC | 2 | $35 | 2025 |
| IRONSHORE PHARMACEUTICALS INC. | 2 | $33 | 2024 |
| Indivior Inc. | 1 | $23 | 2024 |
| ACADIA Pharmaceuticals Inc | 1 | $17 | 2025 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Food and Beverage | 337 | $10,575 |
| Travel and Lodging | 1 | $141 |
| Education | 2 | $116 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-22 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-12-19 | Axsome Therapeutics, Inc. | $25 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-12-18 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $23 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-17 | Tris Pharma Inc | $24 | Food and Beverage | In-kind items and services | Dyanavel XR Drug, ADHD | 2025 | |
| 2025-12-17 | Neurocrine BioSciences, Inc. | $12 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-12-15 | Alkermes, Inc. | $17 | Food and Beverage | In-kind items and services | VIVITROL Drug, CNS | 2025 | |
| 2025-12-15 | Alkermes, Inc. | $0 | Food and Beverage | In-kind items and services | VIVITROL Drug, CNS | 2025 | |
| 2025-12-11 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-12-10 | Otsuka America Pharmaceutical, Inc. | $17 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-12-05 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $7 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-03 | Collegium Pharmaceutical, Inc. | $13 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-12-02 | Janssen Pharmaceuticals, Inc | $11 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-12-02 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-12-02 | Janssen Pharmaceuticals, Inc | $8 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-11-24 | Alkermes, Inc. | $32 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-11-20 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-19 | Neurocrine BioSciences, Inc. | $21 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-11-18 | E.R. Squibb & Sons, L.L.C. | $21 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-12 | Tris Pharma Inc | $23 | Food and Beverage | In-kind items and services | Dyanavel XR Drug, ADHD | 2025 | |
| 2025-11-10 | Otsuka America Pharmaceutical, Inc. | $19 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-11-06 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $121 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-06 | Collegium Pharmaceutical, Inc. | $17 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-11-03 | Alkermes, Inc. | $21 | Food and Beverage | In-kind items and services | VIVITROL Drug, CNS | 2025 | |
| 2025-11-03 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-03 | Alkermes, Inc. | $0 | Food and Beverage | In-kind items and services | VIVITROL Drug, CNS | 2025 | |
| 2025-10-31 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $14 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-30 | Otsuka America Pharmaceutical, Inc. | $21 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-22 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $23 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-20 | Axsome Therapeutics, Inc. | $22 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-10-16 | Janssen Pharmaceuticals, Inc | $111 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-10-14 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-08 | Axsome Therapeutics, Inc. | $22 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-10-06 | Otsuka America Pharmaceutical, Inc. | $11 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-02 | E.R. Squibb & Sons, L.L.C. | $14 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-01 | ABBVIE INC. | $124 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-09-30 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $31 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-09-29 | Collegium Pharmaceutical, Inc. | $12 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-09-26 | Otsuka America Pharmaceutical, Inc. | $22 | Food and Beverage | In-kind items and services | ABILIFY ASIMTUFII Drug, PSYCHIATRY | 2025 | |
| 2025-09-25 | Neurocrine BioSciences, Inc. | $26 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-09-24 | Otsuka America Pharmaceutical, Inc. | $20 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-09-17 | Tris Pharma Inc | $24 | Food and Beverage | In-kind items and services | Dyanavel XR Drug, ADHD | 2025 | |
| 2025-09-16 | Collegium Pharmaceutical, Inc. | $9 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-09-10 | Alkermes, Inc. | $21 | Food and Beverage | In-kind items and services | VIVITROL Drug, CNS | 2025 | |
| 2025-09-10 | Alkermes, Inc. | $0 | Food and Beverage | In-kind items and services | VIVITROL Drug, CNS | 2025 | |
| 2025-09-09 | Neurocrine BioSciences, Inc. | $16 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-09-04 | Janssen Pharmaceuticals, Inc | $20 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-09-03 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-09-02 | Vanda Pharmaceuticals Inc. | $22 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2025 | |
| 2025-08-29 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $3 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-08-28 | ACADIA Pharmaceuticals Inc | $17 | Food and Beverage | In-kind items and services | NUPLAZID Drug, PARKINSONS DISEASE PSYCHOSIS | 2025 | |
| 2025-08-26 | Collegium Pharmaceutical, Inc. | $8 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-08-21 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $31 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-08-20 | Tris Pharma Inc | $22 | Food and Beverage | In-kind items and services | Dyanavel XR Drug, ADHD | 2025 | |
| 2025-08-19 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-16 | Janssen Pharmaceuticals, Inc | $16 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-08-13 | Alkermes, Inc. | $0 | Food and Beverage | In-kind items and services | VIVITROL Drug, CNS | 2025 | |
| 2025-08-12 | Alkermes, Inc. | $13 | Food and Beverage | In-kind items and services | VIVITROL Drug, CNS | 2025 | |
| 2025-08-12 | Alkermes, Inc. | $3 | Food and Beverage | In-kind items and services | VIVITROL Drug, CNS | 2025 | |
| 2025-08-11 | Neos Therapeutics, LP | $19 | Food and Beverage | Cash or cash equivalent | Adzenys XR-ODT Drug, ADHD | 2025 | |
| 2025-08-05 | Axsome Therapeutics, Inc. | $18 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-01 | Axsome Therapeutics, Inc. | $18 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-07-31 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $33 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-07-31 | Collegium Pharmaceutical, Inc. | $14 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-07-30 | Janssen Pharmaceuticals, Inc | $4 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-07-28 | Alkermes, Inc. | $11 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-07-25 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $10 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-07-24 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-21 | Otsuka America Pharmaceutical, Inc. | $22 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-07-14 | Tris Pharma Inc | $20 | Food and Beverage | In-kind items and services | Dyanavel XR Drug, ADHD | 2025 | |
| 2025-07-10 | Alkermes, Inc. | $23 | Food and Beverage | In-kind items and services | VIVITROL Drug, CNS | 2025 | |
| 2025-07-09 | Alkermes, Inc. | $0 | Food and Beverage | In-kind items and services | VIVITROL Drug, CNS | 2025 | |
| 2025-07-07 | Almatica Pharma LLC | $24 | Food and Beverage | In-kind items and services | LOREEV XR Drug, ANTI-ANXIETY | 2025 | |
| 2025-07-03 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $5 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-06-26 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-06-26 | Collegium Pharmaceutical, Inc. | $8 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-06-24 | Janssen Pharmaceuticals, Inc | $19 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-06-19 | Tris Pharma Inc | $24 | Food and Beverage | In-kind items and services | Dyanavel XR Drug, ADHD | 2025 | |
| 2025-06-12 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $32 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-06-10 | Neurocrine BioSciences, Inc. | $26 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-06-03 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-05-13 | Lundbeck LLC | $17 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-05-13 | Teva Pharmaceuticals USA, Inc. | $15 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-05-08 | E.R. Squibb & Sons, L.L.C. | $44 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-05-07 | Tris Pharma Inc | $23 | Food and Beverage | In-kind items and services | Dyanavel XR Drug, ADHD | 2025 | |
| 2025-05-06 | Janssen Pharmaceuticals, Inc | $141 | Travel and Lodging | In-kind items and services | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-05-06 | Janssen Pharmaceuticals, Inc | $26 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-05-06 | Janssen Pharmaceuticals, Inc | $22 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-05-05 | Janssen Pharmaceuticals, Inc | $81 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-05-02 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-05-02 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $7 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-04-30 | Neurocrine BioSciences, Inc. | $27 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-04-24 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $29 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-04-23 | Vanda Pharmaceuticals Inc. | $100 | Food and Beverage | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-04-21 | Janssen Pharmaceuticals, Inc | $40 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-04-21 | Janssen Pharmaceuticals, Inc | $2 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-04-17 | Collegium Pharmaceutical, Inc. | $20 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-04-16 | Tris Pharma Inc | $24 | Food and Beverage | In-kind items and services | Dyanavel XR Drug, ADHD | 2025 | |
| 2025-04-15 | Lundbeck LLC | $18 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-04-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $6 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-04-08 | Otsuka America Pharmaceutical, Inc. | $23 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-04-04 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-04-02 | Neurocrine BioSciences, Inc. | $100 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-04-02 | Neurocrine BioSciences, Inc. | $13 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-03-31 | Vanda Pharmaceuticals Inc. | $11 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2025 | |
| 2025-03-26 | Teva Pharmaceuticals USA, Inc. | $14 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-03-25 | Neurocrine BioSciences, Inc. | $18 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-03-24 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-03-20 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $14 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-03-19 | Janssen Pharmaceuticals, Inc | $125 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-03-18 | Almatica Pharma LLC | $21 | Food and Beverage | In-kind items and services | LOREEV XR Drug, ANTI-ANXIETY | 2025 | |
| 2025-03-13 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-03-12 | Janssen Pharmaceuticals, Inc | $132 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-03-12 | ABBVIE INC. | $125 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-03-11 | Collegium Pharmaceutical, Inc. | $17 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-03-04 | Otsuka America Pharmaceutical, Inc. | $18 | Food and Beverage | In-kind items and services | ABILIFY ASIMTUFII Drug, PSYCHIATRY | 2025 | |
| 2025-02-26 | Janssen Pharmaceuticals, Inc | $5 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-02-25 | Neurocrine BioSciences, Inc. | $21 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-02-20 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-02-18 | Otsuka America Pharmaceutical, Inc. | $13 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-02-14 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-02-13 | Collegium Pharmaceutical, Inc. | $14 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-02-10 | Almatica Pharma LLC | $21 | Food and Beverage | In-kind items and services | LOREEV XR Drug, ANTI-ANXIETY | 2025 | |
| 2025-02-06 | E.R. Squibb & Sons, L.L.C. | $86 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-02-05 | Tris Pharma Inc | $22 | Food and Beverage | In-kind items and services | Dyanavel XR Drug, ADHD | 2025 | |
| 2025-02-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $31 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-02-03 | Collegium Pharmaceutical, Inc. | $15 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-01-24 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-01-21 | Otsuka America Pharmaceutical, Inc. | $17 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-01-16 | Vanda Pharmaceuticals Inc. | $10 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2025 | |
| 2025-01-14 | Tris Pharma Inc | $22 | Food and Beverage | In-kind items and services | Dyanavel XR Drug, ADHD | 2025 | |
| 2025-01-13 | Vanda Pharmaceuticals Inc. | $9 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2025 | |
| 2025-01-06 | Almatica Pharma LLC | $18 | Food and Beverage | In-kind items and services | LOREEV XR Drug, ANTI-ANXIETY | 2025 | |
| 2025-01-03 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2024-12-17 | IRONSHORE PHARMACEUTICALS INC. | $18 | Food and Beverage | Cash or cash equivalent | JORNAY PM Drug, CENTRAL NERVOUS SYSTEM STIMULANT | 2024 | |
| 2024-12-10 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-12-04 | Almatica Pharma LLC | $19 | Food and Beverage | In-kind items and services | LOREEV XR Drug, ANTI-ANXIETY | 2024 | |
| 2024-11-27 | Vanda Pharmaceuticals Inc. | $21 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2024 | |
| 2024-11-21 | Janssen Pharmaceuticals, Inc | $109 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-11-20 | IRONSHORE PHARMACEUTICALS INC. | $15 | Food and Beverage | Cash or cash equivalent | JORNAY PM Drug, CENTRAL NERVOUS SYSTEM STIMULANT | 2024 | |
| 2024-11-12 | Tris Pharma Inc | $23 | Food and Beverage | In-kind items and services | Dyanavel XR Drug, ADHD | 2024 | |
| 2024-11-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $30 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-11-07 | Neurocrine BioSciences, Inc. | $15 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-11-05 | ABBVIE INC. | $3 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-10-28 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-10-15 | Vanda Pharmaceuticals Inc. | $57 | Food and Beverage | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2024 | |
| 2024-10-11 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-10-08 | Otsuka America Pharmaceutical, Inc. | $18 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-10-02 | Vanda Pharmaceuticals Inc. | $27 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2024 | |
| 2024-10-01 | Almatica Pharma LLC | $20 | Food and Beverage | In-kind items and services | LOREEV XR Drug, ANTI-ANXIETY | 2024 | |
| 2024-10-01 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-09-25 | Axsome Therapeutics, Inc. | $15 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-09-18 | Tris Pharma Inc | $23 | Food and Beverage | In-kind items and services | Dyanavel XR Drug, ADHD | 2024 | |
| 2024-09-12 | Janssen Pharmaceuticals, Inc | $109 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2024 | |
| 2024-09-03 | Janssen Pharmaceuticals, Inc | $7 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2024 | |
| 2024-08-27 | Tris Pharma Inc | $23 | Food and Beverage | In-kind items and services | Dyanavel XR Drug, ADHD | 2024 | |
| 2024-08-27 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-08-26 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-08-21 | Biogen, Inc. | $100 | Food and Beverage | In-kind items and services | ZURZUVAE Drug, Neurology | 2024 | |
| 2024-08-14 | Janssen Pharmaceuticals, Inc | $6 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2024 | |
| 2024-08-13 | Alkermes, Inc. | $109 | Food and Beverage | In-kind items and services | VIVITROL Drug, CNS | 2024 | |
| 2024-08-08 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-08-07 | Vanda Pharmaceuticals Inc. | $31 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2024 | |
| 2024-08-05 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $11 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-08-01 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-07-31 | Vanda Pharmaceuticals Inc. | $124 | Food and Beverage | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2024 | |
| 2024-07-18 | Tris Pharma Inc | $21 | Food and Beverage | In-kind items and services | Dyanavel XR Drug, ADHD | 2024 | |
| 2024-07-17 | ABBVIE INC. | $125 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-06-26 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-06-20 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-06-18 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $19 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-06-12 | Tris Pharma Inc | $19 | Food and Beverage | In-kind items and services | Dyanavel XR Drug, ADHD | 2024 | |
| 2024-06-06 | Janssen Pharmaceuticals, Inc | $41 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2024 | |
| 2024-06-05 | Otsuka America Pharmaceutical, Inc. | $16 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-05-30 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-05-23 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $87 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-05-21 | E.R. Squibb & Sons, L.L.C. | $69 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Psychiatry/Psychology | 2024 | |
| 2024-05-15 | Janssen Pharmaceuticals, Inc | $285 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2024 | |
| 2024-05-14 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-05-13 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-05-08 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-04-25 | Tris Pharma Inc | $23 | Food and Beverage | In-kind items and services | Dyanavel XR Drug, ADHD | 2024 | |
| 2024-04-17 | Alkermes, Inc. | $28 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2024 | |
| 2024-04-17 | Otsuka America Pharmaceutical, Inc. | $18 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-04-10 | Tris Pharma Inc | $5 | Food and Beverage | In-kind items and services | Dyanavel XR Drug, ADHD | 2024 | |
| 2024-04-08 | Alkermes, Inc. | $17 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2024 | |
| 2024-04-04 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-03-25 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $21 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-03-20 | Alkermes, Inc. | $88 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2024 | |
| 2024-03-19 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-03-14 | Janssen Pharmaceuticals, Inc | $39 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2024 | |
| 2024-03-14 | Janssen Pharmaceuticals, Inc | $2 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2024 | |
| 2024-03-13 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-03-12 | Alkermes, Inc. | $21 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2024 | |
| 2024-03-06 | Tris Pharma Inc | $23 | Food and Beverage | In-kind items and services | Dyanavel XR Drug, ADHD | 2024 | |
| 2024-03-06 | Indivior Inc. | $23 | Food and Beverage | In-kind items and services | PERSERIS Drug, BH | 2024 | |
| 2024-02-20 | ABBVIE INC. | $22 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-02-15 | Janssen Pharmaceuticals, Inc | $5 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2024 | |
| 2024-02-10 | Alkermes, Inc. | $29 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2024 | |
| 2024-02-07 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $125 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-01-31 | Alkermes, Inc. | $29 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2024 |
The latest 200 records of 340.
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In King, NC, county Stokes County, NC, state North Carolina; placed by its city name.
| Measure | Place (city or town) King, NC | County Stokes County, NC | State North Carolina |
|---|---|---|---|
| Population B01003 | 7,408 | 45,139 | 10,730,404 |
| Population, 2020 census P1 | 7,197 | 44,520 | 10,439,388 |
| Median age B01002 | 42.3 | 47.7 | 39.1 |
| Under 18 B01001 | 21.8% | 18.6% | 21.8% |
| 65 and over B01001 | 23.1% | 23.1% | 17.2% |
| Households B11001 | 3,216 | 19,546 | 4,282,345 |
| Foreign born B05002 | 2.8% | 1.5% | 9.1% |
| Median household income B19013 | $57,817 | $62,969 | $72,388 |
| Median family income B19113 | $80,127 | $76,912 | $90,290 |
| Per capita income B19301 | $34,267 | $33,945 | $41,385 |
| Poverty rate B17001 | 7.0% | 11.2% | 13.0% |
| Unemployment rate B23025 | 1.0% | 3.1% | 4.7% |
| Civilian labor force B23025 | 3,210 | 20,776 | 5,336,863 |
| Mean commute (minutes) B08013 | 24.8 | 31.6 | 25.1 |
| Bachelor's degree or higher B15003 | 22.8% | 18.2% | 35.7% |
| Housing units B25001 | 3,351 | 21,497 | 4,895,668 |
| Owner-occupied B25003 | 65.1% | 79.2% | 66.6% |
| Renters B25003 | 34.9% | 20.8% | 33.4% |
| Median home value B25077 | $238,200 | $196,700 | $288,900 |
| Median gross rent B25064 | $895 | $775 | $1,228 |
| White, not Hispanic B03002 | 81.9% | 89.0% | 60.0% |
| Black B03002 | 6.0% | 3.7% | 20.0% |
| Hispanic or Latino B03002 | 6.2% | 3.8% | 11.3% |
| Asian B03002 | 0.3% | 0.1% | 3.3% |
| American Indian and Alaska Native B03002 | 0.0% | 0.2% | 0.8% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in King, NC.
Comments